Mandate

Vinge advises Industrifonden on the investment in Aprea AB

November 07, 2007

Vinge advises Industrifonden on its investment in Aprea AB, a pharmaceutical company that develops and carries out research on a new drug against cancer. Aprea will raise MSEK 50 through this share issue of which Industrifonden contributes with MSEK 25 and will thereby become a new owner in the company.

Industrifonden is represented by partner Johan Winnerblad with assistance from Johan Larsson.

Related

Vinge has advised Fidelio Capital AB in connection with its investment in Newsec AB

Vinge has advised Fidelio Capital AB in connection with the company’s investment in Newsec AB, a leading property asset management and advisory company in the Nordic and Baltic regions. Fidelio Capital AB has a vision to expand the business through, among other things, acquisitions and digital development within property management.
June 09, 2025

Vinge has advised Brand Equity Group Sweden AB in connection with its acquisition of PREVOX REKLAM Aktiebolag and Jonas Anderzson of Sweden AB

Vinge has advised Brand Equity Group Sweden AB in connection with its parallel acquisitions of PREVOX REKLAM Aktiebolag and Jonas Anderzson of Sweden AB. The acquired businesses are engaged in product media activities, with a primary focus on marketing and production of product media. Through these acquisitions, Brand Equity Group Sweden AB strengthens its position in Sweden within product media and brand communication.
June 09, 2025

Vinge advises Lagercrantz Group in connection with the acquisition of ORAX

Lagercrantz Group has acquired all shares in AB ORAX, a leading provider of products for management and maintenance in the funeral and cemetery sector.
June 04, 2025